eNewsroom for: Morflora


Morflora Company Profile

Morflora develops a bio-based generic and non-transgenic trait introduction solution into plants and seeds, to protect them from a wide variety of diseases, as well as introduce new desired traits for plant and seed enhancement. The company targets the seed treatment market, and non-seed and plant treatment markets with plant protection and enhancement solutions in order to reduce dependency on chemical treatments in plants, and increase global crop yield. So far experiments were conducted in vegetables, vines and trees, and response to a number of pathogens, have yielded promising results. The next step is to explore TraitUP’s™ potential as a plant enhancement solution. Morflora’s combination of independent development efforts, the intellectual property it holds, and the knowledge and expertise of its scientists allows for a unique offering and a technological breakthrough which can significantly affect a wide variety of agricultural markets. TraitUP™ is a patent-pending technology developed at the Hebrew University by Prof. Haim Rabinowitch and Prof. Ilan Sela. The patents are co-owned by Morflora and Yissum and under exclusive licensing agreement with Yissum (Yissum is the technology transfer arm of the Hebrew University of Jerusalem). Established in 2008, the company is supported by private investors.

News from Morflora:

Morflora's TraitUP™ Wins Agrow Awards for the Best Novel Agricultural Biotechnology

TraitUP ™ platform applicability now validated with soy, corn and rice, in addition to vegetable seeds SHARSHERET, Israel, Dec. 4, 2013 /PRNewswire/ — Morflora's revolutionary TraitUP™ technology won the Best Novel Agricultural Biotechnology in the Agrow Awards prestigious co…